Mundipharma Research Limited
Clinical trials sponsored by Mundipharma Research Limited, explained in plain language.
-
New hope for aggressive brain cancer? early trial tests tinostamustine
Disease control CompletedThis early-phase study tested a new drug called tinostamustine in 10 people with a fast-growing brain cancer (glioblastoma) that has a specific genetic marker (unmethylated MGMT). The goal was to see if the drug is safe and to find the best dose when given after standard treatmen…
Phase: EARLY_PHASE1 • Sponsor: Mundipharma Research Limited • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
New drug could shield transplant patients from deadly fungal infections
Prevention CompletedThis study tested a new medicine called rezafungin to see if it can prevent serious fungal infections in adults getting a bone marrow transplant. About 600 participants received either rezafungin or the standard treatment. The goal was to see if rezafungin helps more people stay …
Phase: PHASE3 • Sponsor: Mundipharma Research Limited • Aim: Prevention
Last updated Jun 23, 2026 11:57 UTC